We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

46 hedge funds and large institutions have $61.1M invested in Assembly Biosciences in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 48 → 46 (-2)

34% less capital invested

Capital invested by funds: $92.3M → $61.1M (-$31.1M)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
19
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
QF
QVT Financial
New York
+$1.15M
2
DCM
Dialectic Capital Management
Connecticut
+$317K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$286K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$181K
5
Renaissance Technologies
Renaissance Technologies
New York
+$111K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.48M
2
IHM
Iguana Healthcare Management
New York
-$1.13M
3
GCP
GSA Capital Partners
United Kingdom
-$113K
4
Millennium Management
Millennium Management
New York
-$106K
5
Bank of America
Bank of America
North Carolina
-$91.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Caxton Corporation
New Jersey
$111K +$22.8K +341 +23%
TA
27
Teachers Advisors
New York
$106K – – –
Charles Schwab
28
Charles Schwab
California
$104K – – –
BRWA
29
B. Riley Wealth Advisors
Florida
$99K +$2.74K +41 +3%
Deutsche Bank
30
Deutsche Bank
Germany
$73K +$55.9K +836 +211%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$71K +$468 +7 +0.6%
State Board of Administration of Florida Retirement System
32
State Board of Administration of Florida Retirement System
Florida
$67K – – –
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$66K – – –
Citigroup
34
Citigroup
New York
$59K +$60.4K +903 +1,075%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$56K – – –
CS
36
Credit Suisse
Switzerland
$52K +$2.14K +32 +4%
NFA
37
Nationwide Fund Advisors
Ohio
$46K – – –
AIG
38
American International Group
New York
$42K – – –
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$32K -$19.3K -288 -34%
BA
40
BlackRock Advisors
Delaware
$32K – – –
Morgan Stanley
41
Morgan Stanley
New York
$19K -$1.6K -24 -7%
Wells Fargo
42
Wells Fargo
California
$11K +$4.61K +69 +57%
Bank of America
43
Bank of America
North Carolina
$2K -$91.2K -1,364 -98%
BlackRock
44
BlackRock
New York
$1K +$1.27K +19 New
Geode Capital Management
45
Geode Capital Management
Massachusetts
$440 +$6.55K +98 +1%
Fidelity Investments
46
Fidelity Investments
Massachusetts
– -$1.48M -16,425 Closed
IHM
47
Iguana Healthcare Management
New York
– -$1.13M -12,500 Closed
GCP
48
GSA Capital Partners
United Kingdom
– -$113K -1,256 Closed
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
– -$19.6K -218 Closed
TRCT
50
Tower Research Capital (TRC)
New York
– -$7.42K -111 -97%
1
2
3

ASMB Hedge Fund Activity: Q1 2016 in Review

46 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2016, worth a combined $61.1M — down 34% from $92.3M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ASMB and 3 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 19 added.

The largest buyer was QVT Financial, adding an estimated $1.15M. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.48M sold.

  • 46 institutional investors held Assembly Biosciences (ASMB) as of Q1 2016, down from 48 in Q4 2015.
  • Funds reported $61.1M of Assembly Biosciences stock for Q1 2016, down 34% quarter-over-quarter.
  • 3 funds opened new Assembly Biosciences positions in Q1 2016 and 5 closed out, a net change of -2 holders.
  • The largest Assembly Biosciences buyer in Q1 2016 was QVT Financial, an estimated $1.15M added.
  • The largest Assembly Biosciences seller in Q1 2016 was Fidelity Investments, an estimated $1.48M sold.

Based on aggregated 13F filings for Q1 2016.